Clinical Trials Directory

Trials / Completed

CompletedNCT01304966

Human Papillomatosis Genotyping of Children in Thailand

Human Papillomatosis Genotyping and Severity in Patients With Recurrent Respiratory Papillomatosis of Children in Thailand

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Queen Sirikit National Institute of Child Health · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the present study was to identify risk factors for more severe juvenile Recurrent Respiratory Papillomatosis (RRP) through prospective evaluation of a pediatric population in Thailand by the employing a protocol that includes staging of disease severity using above mentioned staging system at the time of each endoscopic debridement, as well as human papilloma virus (HPV) genotyping.

Detailed description

Recurrent respiratory papillomatosis is caused by human papilloma virus and is the most common benign laryngeal neoplasm in children. Although RRP is rarely fatal, the disease requires prolonged, extensive medical and surgical treatment, and causes physical and emotional suffering in affected children and their families. Although recurrent respiratory papillomatosis is a relatively unusual problem, it accounts for significant health are expenditures.The goal of management of RRP is control of the disease, preservation of the voice and prevention of major complication .The purpose of study will identify risk factors for more severe juvenile RRP through prospective evaluation of a pediatric population in Thailand by the employing a protocol that includes staging of disease severity , as well as HPV genotyping. Objective: * To identify the genotypes of HPV isolated from Thai RRP patients * To compare staging and severity with HPV genotypes * To correlate the following characteristics of the Thai RRP patients with the HPV genotypes

Conditions

Interventions

TypeNameDescription
PROCEDUREbiopsyexcisional biopsy

Timeline

Start date
2011-03-01
Primary completion
2012-09-01
Completion
2012-12-01
First posted
2011-02-28
Last updated
2014-02-17
Results posted
2014-02-17

Locations

2 sites across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01304966. Inclusion in this directory is not an endorsement.